Research Study

Cognitive and Alzheimer's disease biomarker effects of oral nicotinamide riboside (NR) supplementation in older adults with subjective cognitive decline and mild cognitive impairment.

📅 2025 🔗 DOI: 10.1002/trc2.70023
Citation
Wu C., Kupferschmid A., Chen L., McManus A., Kivisäkk P. et al. (2025). Cognitive and Alzheimer's disease biomarker effects of oral nicotinamide riboside (NR) supplementation in older adults with subjective cognitive decline and mild cognitive impairment.. Alzheimers Dement (N Y). DOI: 10.1002/trc2.70023
View Full Study →

Abstract

Abstract not available. See citation for source.

Related Substances

N Acetyl Msh
Disclaimer: This research summary is for educational purposes only. Always consult with a healthcare professional before making decisions based on scientific research.